Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Reproduction, Fertility, and Development|March 5, 2005
The role of early embryonic environment on epigenotype and phenotypeNicola Vickaryous, Emma WhitelawJournal of Neurology|November 5, 2022
Vitamin D genetic risk scores in multiple sclerosisAshvin Kuri, Nicola Vickaryous, Amine Awad, et al.Annals of Clinical and Translational Neurology|January 28, 2024
Plasma proteomic profiles of UK Biobank participants with multiple sclerosisBenjamin M Jacobs, Nicola Vickaryous, Gavin Giovannoni, et al.Multiple Sclerosis and Related Disorders|May 21, 2026
Evaluating the feasibility of a remote sampling method for neurofilament light chain measurements in Multiple SclerosisPanagiotis Gklinos, Nicola Vickaryous, Brook Huxford, et al.Plos One|December 30, 2020
Remote testing of vitamin D levels across the UK MS population-A case control studyNicola Vickaryous, Mark Jitlal, Benjamin Meir Jacobs, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 22, 2023
A phase 2a open-label clinical trial to determine the effect of famciclovir on EBV activity as measured by EBV shedding in the saliva of patients with multiple sclerosisRuth Dobson, David Holden, Nicola Vickaryous, et al.Blood Cells, Molecules & Diseases|October 9, 2012
ENU mutagenesis identifies the first mouse mutants reproducing human β-thalassemia at the genomic levelFiona C Brown, Nicholas Scott, Gerhard Rank, et al.Nature Genetics|April 24, 2007
Modifiers of epigenetic reprogramming show paternal effects in the mouseSuyinn Chong, Nicola Vickaryous, Alyson Ashe, et al.Multiple Sclerosis and Related Disorders|June 14, 2022
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosisEmma C Tallantyre, Martin J Scurr, Nicola Vickaryous, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 11, 2023
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccinationSafiya A Zaloum, Callum H Wood, Pooja Tank, et al.Pageof 2